Country: Singapore
Language: English
Source: HSA (Health Sciences Authority)
Calcium chloride dihydrate (Electrolyte solution); Glucose monohydrate (Electrolyte solution); Magnesium chloride hexahydrate (Electrolyte solution); Sodium chloride (Electrolyte solution); Sodium chloride (Sodium bicarbonate solution); Sodium hydrogen carbonate (Sodium bicarbonate solution)
B. BRAUN SINGAPORE PTE LTD
B05ZB
SOLUTION, STERILE
Calcium chloride dihydrate (Electrolyte solution) 1.98g/1000ml; Glucose monohydrate (Electrolyte solution) 9.90g/1000ml; Magnesium chloride hexahydrate (Electrolyte solution) 0.91g/1000ml; Sodium chloride (Electrolyte solution) 4.21g/1000ml; Sodium chloride (Sodium bicarbonate solution) 6.18g/1000ml; Sodium hydrogen carbonate (Sodium bicarbonate solution) 3.59g/1000ml
INTRAVENOUS
Prescription Only
B. Braun Avitum AG
ACTIVE
2019-08-20
DUOSOL WITHOUT POTASSIUM B. Braun Avitum AG Schwarzenberger Weg 73-79 34212 Melsungen Germany 688995_0822_Duosol_0K_SG_CPP-K01.indd 1 688995_0822_Duosol_0K_SG_CPP-K01.indd 1 29.08.2022 13:37:19 29.08.2022 13:37:19 – 2 – 1. NAME OF THE MEDICINAL PRODUCT Duosol without Potassium solution for haemofiltration 2. QUALITATIVE AND QUANTITATIVE COMPOSITION COMPOSITION OF THE READY-TO-USE SOLUTION FOR HAEMOFILTRATION AFTER MIXING: 1000 ml ready-to-use solution for haemofiltration contain [mmol/l]: Na + 140 Ca 2 + 1.5 Mg 2 + 0.5 Cl – 109 HCO 3 – 35.0 Glucose anhydrous 5.6 (equiv. to 1.0 g) Theoretical osmolarity [mOsm/l] 292 pH 7.0–8.0 For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Solution for haemofiltration Clear and colourless solution, free from visible particles The solution is free from bacterial endotoxins. 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS The ready-to-use solution is indicated for use in patients with acute renal failure requiring continuous haemofiltration. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION The use of solutions for haemofiltration in patients with acute renal failure should be under the direction of a physician with experience in using such treatment. In acute renal failure, treatment is carried out for a limited period and is discontinued when renal function is restored. Posology The filtration rate prescribed is dependent on the clinical status and the body weight of the patient. Unless otherwise prescribed, a filtration rate of 20–25 ml/kg body weight per hour is recommended for the removal of metabolic waste products normally excreted in the urine, depending on the metabolic condition of the patient. A maximum filtration rate of 75 litre per day is recommended. The dose-volume is at the discretion of the physician because the volume of substitution solution depends on the intensity of treatment performed and on the amount of fluid to be replaced in order to achieve fluid balance. Method of administration Intravenous use. The ready-to-use solutio Read the complete document